Razieh Amini, Amir Mohammad Salehi, Fatemeh Torogi, Farid Azizi Jalilian
Journal: MicroRNA (Shariqah, United Arab Emirates) 2025;14(1):42-48
PMID: 39279107
INTRODUCTION
Curcumin is known as a bioactive component that is found in the rhizomes of . Curcumin is well known for its chemo-preventive and anticancer properties. However, its anticancer mechanism in colorectal cancer treatment is unclear, and some studies have shown that many microRNAs (miRs) could be potential targets for curcumin in colorectal cancer (CRC) treatment, so there is a need for their integration and clarification.
METHODS
We systematically searched international databases, including PubMed, Scopus, and Web of Science, until July 2021 by using some relevant keywords.
RESULTS
The search resulted in 87 papers, among which there were 18 related articles. Curcumin was found to cause the upregulation of miR-497, miR-200c, miR-200b, miR-409-3p, miR-34, miR-126, miR-145, miR-206, miR-491, miR-141, miR-429, miR-101, and miR-15a and the downregulation of miR-21, miR-155, miR-221, miR-222, miR-17-5p, miR-130a, miR-27, and miR-20a.
CONCLUSION
The present review study suggests that curcumin may be useful as a novel therapeutic agent for CRC by altering the expression level of miRs.
Copyright© Bentham Science Publishers; For any queries, please email at [email protected].
Full Text Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.